Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 514 | 1,576 | 1,177 | 1,862 | 3,672 |
| Gross Profit | 514 | 1,576 | 1,177 | 1,862 | 3,672 |
| Operating Expenses | 17,094 | 21,275 | 45,241 | 68,674 | 54,390 |
| Operating Income | -16,580 | -19,700 | -44,064 | -66,812 | -50,718 |
| Interest Expense | 0 | 0 | 391 | 345 | 242 |
| Other Income | 3,958 | 206 | 5,433 | 23,848 | 2,165 |
| Pre-tax Income | -12,622 | -19,494 | -39,022 | -43,309 | -48,794 |
| Net Income Continuous | -12,622 | -19,494 | -39,022 | -43,309 | -48,794 |
| Net Income | $-12,622 | $-19,494 | $-39,022 | $-43,309 | $-48,794 |
| EPS Basic Total Ops | -40.70 | -74.81 | -195.82 | -262.93 | -334.43 |
| EPS Basic Continuous Ops | -37.36 | -71.62 | -196.08 | -263.33 | -334.30 |
| EPS Diluted Total Ops | -40.70 | -74.81 | -195.82 | -262.93 | -334.43 |
| EPS Diluted Continuous Ops | -37.36 | -71.62 | -196.08 | -263.33 | -334.30 |
| EBITDA(a) | $-15,822 | $-18,563 | $-42,556 | $-65,436 | $-49,640 |